BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kift RL, Messenger MP, Wind TC, Hepburn S, Wilson M, Thompson D, Smith MW, Sturgeon C, Lewington AJ, Selby PJ, Banks RE. A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine. Ann Clin Biochem 2013;50:236-44. [PMID: 23605129 DOI: 10.1258/acb.2012.012117] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Carter JL, Lamb EJ. Evaluating new biomarkers for acute kidney injury: putting the horse before the cart. Am J Kidney Dis 2014;63:543-6. [PMID: 24670481 DOI: 10.1053/j.ajkd.2014.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kim S, Kim HJ, Ahn HS, Song JY, Um TH, Cho CR, Jung H, Koo HK, Park JH, Lee SS, Park HK. Is plasma neutrophil gelatinase-associated lipocalin a predictive biomarker for acute kidney injury in sepsis patients? A systematic review and meta-analysis. J Crit Care 2016;33:213-23. [PMID: 27017333 DOI: 10.1016/j.jcrc.2016.02.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
3 Albert C, Zapf A, Haase M, Röver C, Pickering JW, Albert A, Bellomo R, Breidthardt T, Camou F, Chen Z, Chocron S, Cruz D, de Geus HRH, Devarajan P, Di Somma S, Doi K, Endre ZH, Garcia-Alvarez M, Hjortrup PB, Hur M, Karaolanis G, Kavalci C, Kim H, Lentini P, Liebetrau C, Lipcsey M, Mårtensson J, Müller C, Nanas S, Nickolas TL, Pipili C, Ronco C, Rosa-Diez GJ, Ralib A, Soto K, Braun-Dullaeus RC, Heinz J, Haase-Fielitz A. Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis. Am J Kidney Dis 2020;76:826-841.e1. [PMID: 32679151 DOI: 10.1053/j.ajkd.2020.05.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
4 Xu W, Tong Y, Li Y. Comparison of Roche Elecsys and Sysmex HISCL immunoassays for the screening of common blood-borne pathogens. Ann Transl Med 2019;7:300. [PMID: 31475170 DOI: 10.21037/atm.2019.05.83] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ratnayake I, Mohamed F, Buckley NA, Gawarammana IB, Dissanayake DM, Chathuranga U, Munasinghe M, Maduwage K, Jayamanne S, Endre ZH, Isbister GK. Early identification of acute kidney injury in Russell's viper (Daboia russelii) envenoming using renal biomarkers. PLoS Negl Trop Dis 2019;13:e0007486. [PMID: 31260445 DOI: 10.1371/journal.pntd.0007486] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Krzeminska E, Wyczalkowska-Tomasik A, Korytowska N, Paczek L. Comparison of Two Methods for Determination of NGAL Levels in Urine: ELISA and CMIA. J Clin Lab Anal 2016;30:956-60. [PMID: 27075972 DOI: 10.1002/jcla.21962] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
7 Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, Mccabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, Mckane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants Appl Res 2018;6:1-528. [DOI: 10.3310/pgfar06030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Chatziharalambous D, Lygirou V, Latosinska A, Stravodimos K, Vlahou A, Jankowski V, Zoidakis J. Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation. PLoS One 2016;11:e0149471. [PMID: 26889680 DOI: 10.1371/journal.pone.0149471] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
9 Haase-Fielitz A, Haase M, Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem. 2014;51:335-351. [PMID: 24518531 DOI: 10.1177/0004563214521795] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 18.3] [Reference Citation Analysis]
10 McCaffrey J, Coupes B, Chaloner C, Webb NJ, Barber R, Lennon R. Towards a biomarker panel for the assessment of AKI in children receiving intensive care. Pediatr Nephrol 2015;30:1861-71. [PMID: 25877916 DOI: 10.1007/s00467-015-3089-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
11 Lipcsey M, Hayward P, Haase M, Haase-Fielitz A, Eastwood G, Peck L, Matalanis G, Bellomo R. Neutrophil gelatinase-associated lipocalin after off pump versus on pump coronary artery surgery. Biomarkers 2014;19:22-8. [PMID: 24475761 DOI: 10.3109/1354750X.2013.863974] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Hansen YBL, Damgaard A, Poulsen JH. Evaluation of NGAL TestTM on Cobas 6000. Scandinavian Journal of Clinical and Laboratory Investigation 2013;74:20-6. [DOI: 10.3109/00365513.2013.855943] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Amaral Pedroso L, Nobre V, Dias Carneiro de Almeida C, da Silva Praxedes MF, Sernizon Guimarães N, Simões E Silva AC, Parreiras Martins MA. Acute kidney injury biomarkers in the critically ill. Clin Chim Acta 2020;508:170-8. [PMID: 32413402 DOI: 10.1016/j.cca.2020.05.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Makris K, Stefani D, Makri E, Panagou I, Lagiou M, Sarli A, Lelekis M, Kroupis C. Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: Analytical performance and establishment of reference values. Clin Biochem 2015;48:1291-7. [PMID: 26297118 DOI: 10.1016/j.clinbiochem.2015.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
15 Ji H, Xu L, Su J, Shen L, Wang H, Wang J, Wang F, Ju S. Absolute quantification of urinary neutrophil gelatinase‐associated lipocalin by ultra‐high‐performance liquid chromatography/tandem mass spectrometry and the diagnostic efficacy of acute kidney injury. Rapid Commun Mass Spectrom 2020;34. [DOI: 10.1002/rcm.8637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chen JJ, Lee TH, Lee CC, Chang CH. Using lipocalin as a prognostic biomarker in acute kidney injury. Expert Rev Mol Diagn 2021;21:455-64. [PMID: 33874823 DOI: 10.1080/14737159.2021.1917384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wijewickrama ES, Mohamed F, Gawarammana IB, Endre ZH, Buckley NA, Isbister GK. Serum and urinary biomarkers for early detection of acute kidney injury following Hypnale spp. envenoming. PLoS Negl Trop Dis 2021;15:e0010011. [PMID: 34871314 DOI: 10.1371/journal.pntd.0010011] [Reference Citation Analysis]
18 Cruz DN, Virzì GM, Brocca A, Ronco C, Giavarina D. A comparison of three commercial platforms for urinary NGAL in critically ill adults. Clin Chem Lab Med 2016;54:353-62. [PMID: 26087067 DOI: 10.1515/cclm-2015-0464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Hall PS, Mitchell ED, Smith AF, Cairns DA, Messenger M, Hutchinson M, Wright J, Vinall-Collier K, Corps C, Hamilton P, Meads D, Lewington A. The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation. Health Technol Assess 2018;22:1-274. [PMID: 29862965 DOI: 10.3310/hta22320] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Marcelletti JF, Evans CL, Saxena M, Lopez AE. Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation. AAPS J 2015;17:939-47. [PMID: 25903932 DOI: 10.1208/s12248-015-9756-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]